Company News Press Release ClearNote Health to Showcase Latest Advancements in Early Cancer Detection Testing at ESMO Congress 2025 cnhnewcorpdev October 17, 2025
Company News Press Release ClearNote Health Receives In Vitro Diagnostic Approval in United Kingdom for Avantect® Multi-Cancer Detection Test and Avantect® Ovarian Cancer Test cnhnewcorpdev September 25, 2025
Event 17th Annual Next Generation Summit | Aug 18-20, 2025 | Washington, D.C. cnhnewcorpdev July 29, 2025
Event 15th Annual World Biomarker & CDx Summit | September 22-25, 2025 | Boston, MA cnhnewcorpdev July 16, 2025
Company News Press Release ClearNote Health Receives First In Vitro Diagnostic Approval for its Avantect® Pancreatic Cancer Test cnhnewcorpdev July 9, 2025
Company News Press Release ClearNote Health Avantect® Pancreatic Cancer Test Enters Patient Enrollment Phase of Groundbreaking UK Study Targeting High-Risk Patients cnhnewcorpdev June 16, 2025
Company News Press Release ClearNote Health to Showcase Latest Advancements in Tumor Subtyping and Circulating Tumor Fraction Technologies at AACR Annual Meeting 2025 cnhnewcorpdev April 23, 2025
